Medtronic plc filings document material events, capital structure, registered securities, governance matters, and operating and financial disclosures for a medical-device company organized in Ireland. The 8-K record identifies MDT ordinary shares and multiple series of senior notes listed on the New York Stock Exchange, alongside current reports used for company events and financial-result communications.
The filing record also includes exchange and registration status for debt securities, including a Form 25 notice tied to removal from listing and registration of a guarantor class of senior notes. These disclosures frame Medtronic's public-company obligations around equity, debt instruments, material agreements, and regulatory or clinical developments.
Medtronic plc (MDT) reported that Chief Accounting Officer Denise L. Blomquist made a bona fide gift of 600 Ordinary Shares on September 15, 2026. The gift carried no stated per-share consideration, and Blomquist now holds 16,398 Ordinary Shares directly after the transaction. No Rule 10b5-1 trading plan is reported.
Medtronic plc (MDT) is the issuer of common stock that a holder, Harry Kiil, has notified an intention to sell under Rule 144. The notice covers 1,483 shares of common stock that arose from restricted stock vesting as compensation on July 31, 2026, with potential sales on the NYSE.
Medtronic plc (symbol: MDT) is the issuer of record for a Form 425 filing submitted to the SEC.
Medtronic plc (symbol: MDT) is the issuer of record for a Form 425 filing submitted to the SEC.
Medtronic plc (MDT) describes an exchange offer under which it plans to split off its remaining equity interest in MiniMed Group, Inc., in connection with MiniMed becoming an independent company. Medtronic and MiniMed have filed a Form S-4 registration statement and Medtronic has filed a Schedule TO with the SEC, and the exchange offer is being made solely by the related Prospectus delivered to holders of Medtronic ordinary shares. The communication emphasizes that it is not itself an offer or recommendation and directs investors to the Prospectus and SEC filings for full details.
Medtronic plc (symbol: MDT) is the issuer of record for a Form 425 filing submitted to the SEC.
Medtronic plc (MDT) is moving to complete the separation of its diabetes business through an exchange offer in which Medtronic shareholders may choose to exchange their Medtronic ordinary shares for shares of common stock of its former subsidiary, MiniMed Group, Inc., subject to the terms of the offer. Once the exchange offer and related transactions are completed, Medtronic will no longer hold any equity interest in MiniMed, which will then operate as an independent public company focused on diabetes technology. The communication notes that MiniMed has reached $3 billion in annual revenue, launched new products, and built standalone capabilities as part of the transition, while Medtronic continues to provide transition services during the separation period.
Medtronic plc (symbol: MDT) is the issuer of record for a Form 425 filing submitted to the SEC.